Výsledky vyhledávání - Carlos Garcı́a-Echeverrı́a
- Zobrazuji výsledky 1 - 20 z 37
- Přejít na další stránku
-
1
-
2
Antibody–drug conjugates—A new wave of cancer drugs Autor Hervé Bouchard, Christian Viskov, Carlos Garcı́a-Echeverrı́a
Vydáno 2014Revisão -
3
-
4
Antennapedia and HIV Transactivator of Transcription (TAT) “Protein Transduction Domains” Promote Endocytosis of High Molecular Weight Cargo upon Binding to Cell Surface Glycosamin... Autor Sandra Console, Cornelia Marty, Carlos Garcı́a-Echeverrı́a, Reto A. Schwendener, Kurt Ballmer‐Hofer
Vydáno 2003Artigo -
5
Development of Ewing's Sarcoma from Primary Bone Marrow–Derived Mesenchymal Progenitor Cells Autor Nicolò Riggi, Luisa Cironi, Paolo Provero, Mario-Luca Suvà, Konstantinos Kaloulis, Carlos Garcı́a-Echeverrı́a, Francesco Hoffmann, Andreas Trumpp, Ivan Stamenkovic
Vydáno 2005Artigo -
6
The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations Autor Anna Dubrovska, Sungeun Kim, Richard J. Salamone, John R. Walker, Sauveur-Michel Maira, Carlos Garcı́a-Echeverrı́a, Peter G. Schultz, Venkateshwar A. Reddy
Vydáno 2008Artigo -
7
Specific apoptosis induction by the dual PI3K/mTor inhibitor NVP-BEZ235 in HER2 amplified and PIK3CA mutant breast cancer cells Autor Saskia M. Brachmann, Irmgard Hofmann, Christian Schnell, Christine Fritsch, Susan Wee, Heidi A. Lane, Shaowen Wang, Carlos Garcı́a-Echeverrı́a, Sauveur-Michel Maira
Vydáno 2009Artigo -
8
Preclinical <i>In vivo</i> Study of New Insulin-Like Growth Factor-I Receptor–Specific Inhibitor in Ewing's Sarcoma Autor Maria Cristina Manara, Lorena Landuzzi, Patrizia Nanni, Giordano Nicoletti, Diana Zambelli, Pier‐Luigi Lollini, Cristina Nanni, Francesco Hofmann, Carlos Garcı́a-Echeverrı́a, Piero Picci, Katia Scotlandi
Vydáno 2007Artigo -
9
Targeting Melanoma with Dual Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Inhibitors Autor Romina Marone, Dominik Erhart, Ann C. Mertz, Thomas Bohnacker, Christian Schnell, Vladimir Cmiljanović, Frédéric Stauffer, Carlos Garcı́a-Echeverrı́a, Bernd Giese, Sauveur-Michel Maira, Matthias P. Wymann
Vydáno 2009Artigo -
10
Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor–positive human breast cancer Autor Todd W. Miller, Bryan T. Hennessy, Ana M. González-Angulo, Emily M. Fox, Gordon B. Mills, Heidi Chen, Catherine Higham, Carlos Garcı́a-Echeverrı́a, Yu Shyr, Carlos L. Arteaga
Vydáno 2010Artigo -
11
NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models Autor Michael Rugaard Jensen, Joseph Schoepfer, Thomas Radimerski, Andrew J. Massey, Chantale T. Guy, Josef Brueggen, Cornelia Quadt, Alan Buckler, Robert Cozens, Martin J. Drysdale, Carlos Garcı́a-Echeverrı́a, Patrick Chêne
Vydáno 2008Artigo -
12
NVP-BEZ235 as a New Therapeutic Option for Sarcomas Autor Maria Cristina Manara, Giordano Nicoletti, Diana Zambelli, Selena Ventura, Clara Guerzoni, Lorena Landuzzi, Pier‐Luigi Lollini, Saveur-Michel Maira, Carlos Garcı́a-Echeverrı́a, Mario Mercuri, Piero Picci, Katia Scotlandi
Vydáno 2010Artigo -
13
Antitumor Activity of the Insulin-Like Growth Factor-I Receptor Kinase Inhibitor NVP-AEW541 in Musculoskeletal Tumors Autor Katia Scotlandi, Maria Cristina Manara, Giordano Nicoletti, Pier‐Luigi Lollini, Stella Lukas, Stefania Benini, Stefania Croci, Stefania Perdichizzi, Diana Zambelli, Massimo Serra, Carlos García-Echeverría, Francesco Hofmann, Piero Picci
Vydáno 2005Artigo -
14
-
15
Effects of the Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235 on the Tumor Vasculature: Implications for Clinical Imaging Autor Christian Schnell, Frédéric Stauffer, Peter R. Allegrini, Terence O’Reilly, Paul M.J. McSheehy, Celine Dartois, Michael Stumm, Robert Cozens, Amanda Littlewood‐Evans, Carlos García-Echeverría, Sauveur-Michel Maira
Vydáno 2008Artigo -
16
FGFR2 Promotes Breast Tumorigenicity through Maintenance of Breast Tumor-Initiating Cells Autor Sungeun Kim, Anna Dubrovska, Richard J. Salamone, John R. Walker, Kathryn B. Grandinetti, Ghislain M. C. Bonamy, Anthony P. Orth, Jimmy Elliott, Diana Graus Porta, Carlos Garcı́a-Echeverrı́a, Venkateshwar A. Reddy
Vydáno 2013Artigo -
17
Preclinical Antitumor Activity of the Orally Available Heat Shock Protein 90 Inhibitor NVP-BEP800 Autor Andrew J. Massey, Joseph Schoepfer, Paul A. Brough, Josef Brueggen, Patrick Chêne, Martin J. Drysdale, Ulrike Pfaar, Thomas Radimerski, Stephan Ruetz, Alain Schweitzer, Mike Wood, Carlos Garcı́a-Echeverrı́a, Michael Rugaard Jensen
Vydáno 2010Artigo -
18
Differential induction of apoptosis in HER2 and EGFR addicted cancers following PI3K inhibition Autor Anthony C. Faber, Danan Li, Young-Chul Song, Mei‐Chih Liang, Beow Y. Yeap, Roderick T. Bronson, Eugene Lifshits, Chen Zhao, Sauveur-Michel Maira, Carlos Garcı́a-Echeverrı́a, Kwok‐Kin Wong, Jeffrey A. Engelman
Vydáno 2009Artigo -
19
Combination Therapy Targeting Both Tumor-Initiating and Differentiated Cell Populations in Prostate Carcinoma Autor Anna Dubrovska, Jimmy Elliott, Richard J. Salamone, Sungeun Kim, Lindsey J. Aimone, John R. Walker, J. P. Watson, Sauveur-Michel Maira, Carlos Garcı́a-Echeverrı́a, Charles Y. Cho, Venkateshwar A. Reddy, Peter G. Schultz
Vydáno 2010Artigo -
20
Antimyeloma Activity of the Orally Bioavailable Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235 Autor Douglas W. McMillin, Melissa Ooi, Jake Delmore, Joseph Negri, Patrick Hayden, Nicholas Mitsiades, Jana Jakubı́ková, Sauveur-Michel Maira, Carlos Garcı́a-Echeverrı́a, Robert Schlossman, Nikhil C. Munshi, Paul G. Richardson, Kenneth C. Anderson, Constantine S. Mitsiades
Vydáno 2009Artigo
Vyhledávací nástroje:
Související témata
Biology
Cancer research
Medicine
Cancer
Biochemistry
Internal medicine
Chemistry
PI3K/AKT/mTOR pathway
Cell biology
Genetics
Pharmacology
Signal transduction
Gene
Protein kinase B
In vivo
Kinase
Biotechnology
PTEN
Pathology
Apoptosis
Breast cancer
Immunology
KRAS
Receptor
In vitro
Sarcoma
Cancer cell
Carcinogenesis
Cell
Cell growth